Cite
HARVARD Citation
Sinha, M. et al. (2021). Pre-existing immune status associated with response to combination of sipuleucel-T and ipilimumab in patients with metastatic castration-resistant prostate cancer. Journal for immunotherapy of cancer. 9 (5), p. . [Online].